Annotation Detail

Information
Associated Genes
CD14
Associated Variants
CD14 MUTATION
CD14 MUTATION
Associated Disease
HIV Infections
Source Database
DisGeNET
Description
Maintenance of virologic efficacy and decrease in levels of β2-microglobulin, soluble CD40L and soluble CD14 after switching previously treated HIV-infected patients to an NRTI-sparing dual therapy.
Pubmed
25173576
Section of the abstract supporting the evidence
TITLE
Number of the section of the abstract supporting the evidence
0
Number of the sentence supporting the evidence
0
Original source reporting the Gene Disease association
BeFree
DisGENET score for the Gene Disease association
0.0078718142903288
Drugs